EQS-Adhoc: Vitruvia Medical AG: Annual results as of December 31, 2024 (German)
EQS-Adhoc: Vitruvia Medical AG: Annual results as of December 31, 2024 (German). Vitruvia Medical AG: Annual results as of December 31, 2024 EQS-Ad-hoc: Vitruvia Medical AG / Key word(s): Annual Results Vitruvia Medical AG: Annual results as of December 31.
Vitruvia Medical AG: Annual results as of December 31, 2024
EQS-Ad-hoc: Vitruvia Medical AG / Key word(s): Annual Results Vitruvia Medical AG: Annual results as of December 31, 2024 03.05.2025 / 07:57 CET/CEST Publication of inside information pursuant to Article 17 of the Regulation (EU) No. 596/2014, transmitted by EQS News - a service of the EQS Group. The issuer/publisher is responsible for the content of this announcement. --------------------------------------------------------------------------- Vitruvia Medical AG: Annual results as of December 31, 2024 Anglikon, 3 May 2025: Vitruvia Medical AG achieved 2024 a result after taxes of CHF -173,775.93 compared to the previous year of CHF -243,896.10. On a consolidated basis, Vitruvia Medical AG achieved sales of EUR 2,108,483 (previous year EUR 1,757,724 / +20%) and an operating Earnings before interest, taxes, depreciation and amortization (EBITA) of EUR 178,398.-, compared to the previous year of EUR 61,078 (+192%). The result after taxes and amortization of goodwill amounts to EUR -384,086 compared to the previous year of EUR -535,435 LT technologies has achieved its sales and profit targets for 2024. For 2025, we expect a further increase Activity of LT technologies, which is reflected in the sales and profit figures will be struck down. About Vitruvia Medical AG: Vitruvia Medical AG is a Swiss investment company with the focus on repair, production and trade of medical devices as well as surgical instruments. Vitruvia combines innovative and sustainable solutions for the medical-technical progress, customer benefits and the economic success. End of insider information --------------------------------------------------------------------------- 03.05.2025 CET/CEST The EQS Distribution Services include statutory Reporting obligations, corporate/financial news and press releases. Media archive at https://eqs-news.com --------------------------------------------------------------------------- Language: German Company: Vitruvia Medical AG Kesselackerstr. 18 5611 Anglikon Switzerland Phone: +41 44 915 33 78 Email: [email protected] Internet: www.vitruvia-med.com ISIN: CH0461931419 WKN: A2PDWF Stock exchanges: Open market in Munich EQS News ID: 2129406 End of message EQS News Service --------------------------------------------------------------------------- 2129406 03.05.2025 CET/CEST
ad-hoc-news
